rhodamine b has been researched along with Mucopolysaccharidoses in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Borysiewicz, E; Gabig-Cimińska, M; Jakóbkiewicz-Banecka, J; Narajczyk, M; Piotrowska, E; Słomińska-Wojewódzka, M; Węgrzyn, A; Węgrzyn, G | 1 |
Byers, S; Derrick-Roberts, AL; Marais, W | 1 |
1 review(s) available for rhodamine b and Mucopolysaccharidoses
Article | Year |
---|---|
Substrate reduction therapies for mucopolysaccharidoses.
Topics: Animals; Gene Expression; Glycosaminoglycans; Humans; Isoflavones; Lysosomes; Mucopolysaccharidoses; Neurodegenerative Diseases; Rhodamines; RNA Interference; RNA, Small Interfering; Substrate Specificity | 2011 |
1 other study(ies) available for rhodamine b and Mucopolysaccharidoses
Article | Year |
---|---|
Rhodamine B and 2-acetamido-1,3,6-tri-O-acetyl-4-deoxy-4-fluoro-D-glucopyranose (F-GlcNAc) inhibit chondroitin/dermatan and keratan sulphate synthesis by different mechanisms in bovine chondrocytes.
Topics: Acetylglucosamine; Animals; Cartilage; Cattle; Chondrocytes; Chondroitin Sulfates; Dermatan Sulfate; Gene Expression Profiling; Gene Expression Regulation; Glycosaminoglycans; Keratan Sulfate; Mucopolysaccharidoses; Proteoglycans; Rhodamines | 2012 |